Clinical trial
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With…
NCT00483782 · Medical Research Council, Other · Completed
Key facts
| NCT number | NCT00483782 |
|---|---|
| Title | Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer |
| Official title | ICON7 - A Randomised, Two-Arm, Multi-Centre Gynaecologic Cancer InterGroup Trial of Adding Bevacizumab to Standard Chemotherapy (Carboplatin and Paclitaxel) in Patients With Epithelial Ovarian Cancer |
| Lead sponsor | Medical Research Council, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer |
| Intervention type | Biological, Drug, Other, Procedure |
| Interventions | bevacizumab, carboplatin, paclitaxel, questionnaire administration, study of socioeconomic and demographic variables, quality-of-life assessment |
| Enrollment | 1,520 |
| Start date | Apr 1, 2006 |
| First posted | Jun 7, 2007 |
| Last update posted | Aug 12, 2013 |
| Countries | Australia, France, Germany, Norway, United Kingdom |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: